Cargando…

Inactivation of human myeloperoxidase by hydrogen peroxide()

Human myeloperoxidase (MPO) uses hydrogen peroxide generated by the oxidative burst of neutrophils to produce an array of antimicrobial oxidants. During this process MPO is irreversibly inactivated. This study focused on the unknown role of hydrogen peroxide in this process. When treated with low co...

Descripción completa

Detalles Bibliográficos
Autores principales: Paumann-Page, Martina, Furtmüller, Paul G., Hofbauer, Stefan, Paton, Louise N., Obinger, Christian, Kettle, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808540/
https://www.ncbi.nlm.nih.gov/pubmed/24035742
http://dx.doi.org/10.1016/j.abb.2013.09.004
_version_ 1782288606681890816
author Paumann-Page, Martina
Furtmüller, Paul G.
Hofbauer, Stefan
Paton, Louise N.
Obinger, Christian
Kettle, Anthony J.
author_facet Paumann-Page, Martina
Furtmüller, Paul G.
Hofbauer, Stefan
Paton, Louise N.
Obinger, Christian
Kettle, Anthony J.
author_sort Paumann-Page, Martina
collection PubMed
description Human myeloperoxidase (MPO) uses hydrogen peroxide generated by the oxidative burst of neutrophils to produce an array of antimicrobial oxidants. During this process MPO is irreversibly inactivated. This study focused on the unknown role of hydrogen peroxide in this process. When treated with low concentrations of H(2)O(2) in the absence of reducing substrates, there was a rapid loss of up to 35% of its peroxidase activity. Inactivation is proposed to occur via oxidation reactions of Compound I with the prosthetic group or amino acid residues. At higher concentrations hydrogen peroxide acts as a suicide substrate with a rate constant of inactivation of 3.9 × 10(−3) s(−1). Treatment of MPO with high H(2)O(2) concentrations resulted in complete inactivation, Compound III formation, destruction of the heme groups, release of their iron, and detachment of the small polypeptide chain of MPO. Ten of the protein’s methionine residues were oxidized and the thermal stability of the protein decreased. Inactivation by high concentrations of H(2)O(2) is proposed to occur via the generation of reactive oxidants when H(2)O(2) reacts with Compound III. These mechanisms of inactivation may occur inside neutrophil phagosomes when reducing substrates for MPO become limiting and could be exploited when designing pharmacological inhibitors.
format Online
Article
Text
id pubmed-3808540
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-38085402013-11-01 Inactivation of human myeloperoxidase by hydrogen peroxide() Paumann-Page, Martina Furtmüller, Paul G. Hofbauer, Stefan Paton, Louise N. Obinger, Christian Kettle, Anthony J. Arch Biochem Biophys Article Human myeloperoxidase (MPO) uses hydrogen peroxide generated by the oxidative burst of neutrophils to produce an array of antimicrobial oxidants. During this process MPO is irreversibly inactivated. This study focused on the unknown role of hydrogen peroxide in this process. When treated with low concentrations of H(2)O(2) in the absence of reducing substrates, there was a rapid loss of up to 35% of its peroxidase activity. Inactivation is proposed to occur via oxidation reactions of Compound I with the prosthetic group or amino acid residues. At higher concentrations hydrogen peroxide acts as a suicide substrate with a rate constant of inactivation of 3.9 × 10(−3) s(−1). Treatment of MPO with high H(2)O(2) concentrations resulted in complete inactivation, Compound III formation, destruction of the heme groups, release of their iron, and detachment of the small polypeptide chain of MPO. Ten of the protein’s methionine residues were oxidized and the thermal stability of the protein decreased. Inactivation by high concentrations of H(2)O(2) is proposed to occur via the generation of reactive oxidants when H(2)O(2) reacts with Compound III. These mechanisms of inactivation may occur inside neutrophil phagosomes when reducing substrates for MPO become limiting and could be exploited when designing pharmacological inhibitors. Academic Press 2013-11-01 /pmc/articles/PMC3808540/ /pubmed/24035742 http://dx.doi.org/10.1016/j.abb.2013.09.004 Text en © 2013 The Authors https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Article
Paumann-Page, Martina
Furtmüller, Paul G.
Hofbauer, Stefan
Paton, Louise N.
Obinger, Christian
Kettle, Anthony J.
Inactivation of human myeloperoxidase by hydrogen peroxide()
title Inactivation of human myeloperoxidase by hydrogen peroxide()
title_full Inactivation of human myeloperoxidase by hydrogen peroxide()
title_fullStr Inactivation of human myeloperoxidase by hydrogen peroxide()
title_full_unstemmed Inactivation of human myeloperoxidase by hydrogen peroxide()
title_short Inactivation of human myeloperoxidase by hydrogen peroxide()
title_sort inactivation of human myeloperoxidase by hydrogen peroxide()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808540/
https://www.ncbi.nlm.nih.gov/pubmed/24035742
http://dx.doi.org/10.1016/j.abb.2013.09.004
work_keys_str_mv AT paumannpagemartina inactivationofhumanmyeloperoxidasebyhydrogenperoxide
AT furtmullerpaulg inactivationofhumanmyeloperoxidasebyhydrogenperoxide
AT hofbauerstefan inactivationofhumanmyeloperoxidasebyhydrogenperoxide
AT patonlouisen inactivationofhumanmyeloperoxidasebyhydrogenperoxide
AT obingerchristian inactivationofhumanmyeloperoxidasebyhydrogenperoxide
AT kettleanthonyj inactivationofhumanmyeloperoxidasebyhydrogenperoxide